RONDELLE LONGENECKER: Open Payments
NPI 1669622890 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 43 payments from 13 companies in 2025. Trend: 2023 $1,448 · 2024 $1,210 · 2025 $1,142
Food & beverage: $1,142
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $152 |
| AstraZeneca Pharmaceuticals LP | 8 | $144 |
| Calliditas Therapeutics US Inc. | 4 | $144 |
| SCPHARMACEUTICALS INC. | 1 | $110 |
| Vifor Pharma, Inc. | 4 | $87 |
| Fresenius USA Marketing, Inc. | 3 | $73 |
| Lilly USA, LLC | 3 | $60 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
Products named: JARDIANCE, TARPEYO, FUROSCIX, XPHOZAH 30 MG, LOKELMA, Veltassa, VELPHORO, IBSRELA.
Industry payments across PA — which companies pay providers there.
